These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 20068157)
1. SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Tseng RC; Lee SH; Hsu HS; Chen BH; Tsai WC; Tzao C; Wang YC Cancer Res; 2010 Jan; 70(2):543-51. PubMed ID: 20068157 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914 [TBL] [Abstract][Full Text] [Related]
3. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin. Shi R; Yang Z; Liu W; Liu B; Xu Z; Zhang Z Oncol Rep; 2014 Feb; 31(2):812-8. PubMed ID: 24297051 [TBL] [Abstract][Full Text] [Related]
5. Slit2/Robo1 signaling inhibits small-cell lung cancer by targeting β-catenin signaling in tumor cells and macrophages. Ahirwar DK; Peng B; Charan M; Misri S; Mishra S; Kaul K; Sassi S; Gadepalli VS; Siddiqui J; Miles WO; Ganju RK Mol Oncol; 2023 May; 17(5):839-856. PubMed ID: 35838343 [TBL] [Abstract][Full Text] [Related]
6. SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3β signaling pathway. Chen WF; Gao WD; Li QL; Zhou PH; Xu MD; Yao LQ Int J Colorectal Dis; 2013 Jul; 28(7):933-40. PubMed ID: 23314850 [TBL] [Abstract][Full Text] [Related]
7. Slit2/Robo1 signaling promotes intestinal tumorigenesis through Src-mediated activation of the Wnt/β-catenin pathway. Zhang QQ; Zhou DL; Lei Y; Zheng L; Chen SX; Gou HJ; Gu QL; He XD; Lan T; Qi CL; Li JC; Ding YQ; Qiao L; Wang LJ Oncotarget; 2015 Feb; 6(5):3123-35. PubMed ID: 25605242 [TBL] [Abstract][Full Text] [Related]
8. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
9. Expression of p130cas, E-cadherin and β-catenin and their correlation with clinicopathological parameters in non-small cell lung cancer: p130cas over-expression predicts poor prognosis. Miao Y; Li AL; Wang L; Fan CF; Zhang XP; Xu HT; Han Y; Liu Y; Wang E Folia Histochem Cytobiol; 2012 Oct; 50(3):392-7. PubMed ID: 23042269 [TBL] [Abstract][Full Text] [Related]
10. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer. Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances. Mitra S; Mazumder-Indra D; Mondal RK; Basu PS; Roy A; Roychoudhury S; Panda CK PLoS One; 2012; 7(6):e38342. PubMed ID: 22719878 [TBL] [Abstract][Full Text] [Related]
12. Low Expression of Slit2 and Robo1 is Associated with Poor Prognosis and Brain-specific Metastasis of Breast Cancer Patients. Qin F; Zhang H; Ma L; Liu X; Dai K; Li W; Gu F; Fu L; Ma Y Sci Rep; 2015 Sep; 5():14430. PubMed ID: 26400100 [TBL] [Abstract][Full Text] [Related]
13. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery. Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184 [TBL] [Abstract][Full Text] [Related]
14. Frequent alterations of SLIT2-ROBO1-CDC42 signalling pathway in breast cancer: clinicopathological correlation. Bhattacharya R; Mukherjee N; Dasgupta H; Islam MS; Alam N; Roy A; Das P; Roychoudhury S; Panda CK J Genet; 2016 Sep; 95(3):551-63. PubMed ID: 27659325 [TBL] [Abstract][Full Text] [Related]
15. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma. Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227 [TBL] [Abstract][Full Text] [Related]
16. Slit2 and Robo1 induce opposing effects on metastasis of hepatocellular carcinoma Sk-hep-1 cells. Yuan M; Guo H; Li J; Sui C; Qin Y; Wang J; Khan YH; Ye L; Xie F; Wang H; Yuan L; Ye J Int J Oncol; 2016 Jul; 49(1):305-15. PubMed ID: 27176045 [TBL] [Abstract][Full Text] [Related]
17. Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT. Xia Y; Wang L; Xu Z; Kong R; Wang F; Yin K; Xu J; Li B; He Z; Wang L; Xu H; Zhang D; Yang L; Wu JY; Xu Z Cell Prolif; 2019 May; 52(3):e12606. PubMed ID: 30896071 [TBL] [Abstract][Full Text] [Related]
18. Posttranslational modification of E-cadherin by core fucosylation regulates Src activation and induces epithelial-mesenchymal transition-like process in lung cancer cells. Shao K; Chen ZY; Gautam S; Deng NH; Zhou Y; Wu XZ Glycobiology; 2016 Feb; 26(2):142-54. PubMed ID: 26443198 [TBL] [Abstract][Full Text] [Related]
19. Slit2 expression and its correlation with subcellular localization of β-catenin in gastric cancer. Shi R; Liu W; Liu B; Xu Z; Chen L; Zhang Z Oncol Rep; 2013 Oct; 30(4):1883-9. PubMed ID: 23933755 [TBL] [Abstract][Full Text] [Related]
20. Wnt signaling pathway in non-small cell lung cancer. Stewart DJ J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]